Anika Therapeutics (ANIK) Goodwill (2010 - 2026)

Anika Therapeutics (ANIK) has 17 years of Goodwill data on file, last reported at $7.9 million in Q1 2026.

• On a quarterly basis, Goodwill rose 6.32% year-over-year to $7.9 million in Q1 2026; TTM through Mar 2026 was $7.9 million, a 6.32% increase from a year earlier, with the FY2025 full-year figure at $8.1 million, up 13.04% from the prior year.
• Goodwill for Q1 2026 stood at $7.9 million, down from $8.1 million in the prior quarter.
• Over the last five years, Goodwill for ANIK reached as high as $8.1 million in Q2 2025 and fell as low as $6.7 million in Q3 2022.
• Historically, Goodwill has averaged $7.5 million across 5 years, with a median of $7.5 million in 2023.
• Across the five-year window, Goodwill fell 15.46% in 2022 and gained 13.04% in 2025, its largest moves.
• Year by year, Goodwill stood at $7.3 million in 2022, then grew by 3.16% to $7.6 million in 2023, then dropped by 5.89% to $7.1 million in 2024, then increased by 13.04% to $8.1 million in 2025, then retreated by 2.01% to $7.9 million in 2026.
• Per Business Quant data, the three most recent Goodwill figures were $7.9 million in Q1 2026, $8.1 million in Q4 2025, and $8.1 million in Q3 2025.